7th Circuit Dupixent news shows skin cancer cases across Illinois, Indiana, and Wisconsin. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims.
To learn more, please see our information on claiming a 7th Circuit Dupixent settlement.
Illinois Dupixent News
Illinois Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- IL Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing an Illinois Dupixent lawsuit.
Indiana Dupixent News
Indiana Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- IN Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing an Indiana Dupixent lawsuit.
Wisconsin Dupixent News
Wisconsin Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- WI Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Wisconsin Dupixent lawsuit.
7th Circuit Dupixent News Supports MDL Settlement for Skin Cancer
7th Circuit Dupixent news of T-cell lymphoma has raised concerns for eczema and asthma patients in Illinois, Indiana, and Wisconsin. As such, public support is growing for the court’s certification of a Dupixent Multi-District Litigation (MDL) to administer claims.
Lymphoma Attorneys Act on 7th Circuit Dupixent News of Skin Cancer
Reporting skin cancer is an important first step to justice. If your family has been impacted by Dupixent, contact us about filing a 7th Circuit settlement claim.
For background information on T-cell lymphoma, please see our Dupixent lawyers homepage.